Table I.
Physical and metabolic characteristics the sample population (n=156)
| Mean ± SD or % Frequency |
Range | |
|---|---|---|
| Age (years) | 15.1 ± 2.4 | 8–18 |
| Gender (% Male/ % Female) | 55 / 45 | - |
| Ethnicity (% African-American/ % Latino) | 35 / 65 | - |
| Pubertal Stage by Tanner (%) | ||
| 1 | 11 | - |
| 2 | 8 | - |
| 3 | 1 | - |
| 4 | 16 | - |
| 5 | 64 | - |
| Height (cm) | 162.2 ± 12.5 | 126.1 – 192.9 |
| Weight (kg) | 84.0 ± 22.6 | 32.3 – 144.0 |
| BMI (kg/m2) | 31.5 ± 6.3 | 18.8 – 51.6 |
| BMI percentile | 96.5 ± 3.3 | 85.9 – 99.9 |
| BMI z-score | 1.98 ± 0.46 | 1.08 – 3.21 |
| Total Percent Fat (%) | 36.7 ± 7.4 | 16.7 – 54.2 |
| CIMT (mm) | 0.622 ± 0.058 | 0.47 – 0.76 |
| Traditional CIMT correlates | ||
| Systolic Blood Pressure (mmHg) | 117.0 ± 12.4 | 92.0 – 156.0 |
| Diastolic Blood Pressure (mmHg) | 66.3 ± 6.3 | 50.0 – 86.0 |
| Fasting glucose (mg/dL) | 86.7 ± 6.4 | 66.0 – 111.0 |
| Fasting insulin (µU/ml) | 16.6 ± 12.2 | 2.9 – 102.9 |
| LDL-cholesterol (mg/dL) | 80.8 ± 27.9 | 14.0 – 172.0 |
| HDL-cholesterol (mg/dL) | 40.7 ± 12.1 | 24.0 – 92.0 |
| Cortisol measures | ||
| Salivary Cortisol2200 hrs (µg/dL) | 0.155 ± 0.161 | 0.01 – 1.32 |
| Salivary Cortisol0530hrs (µg/dL) | 0.840 ± 0.507 | 0.01 – 2.59 |
| Nocturnal Cortisol Rise (µg/dL) | 0.685 ± 0.527 | −0.39 – 2.53 |
| Cortisol Awakening Response (µg/dL) | 0.861 ± 0.624 | −0.53 – 2.90 |
| Serum Cortisol (µg/dL) | 10.8 ± 3.8 | 2.5 – 21.2 |
| Urinary Free Cortisol (µg/m2) | 5.06 ± 5.38 | 0.02 – 36.40 |
| Inflammatory Markers | ||
| CRP (ng/mL) | 2438 ± 3069 | 6.5 – 21834.6 |
| IL-6 (pg/mL) | 2.04 ± 2.32 | 0.36 – 19.17 |
| TNF-α (pg/mL) | 1.66 ± 1.78 | 0.07 – 15.93 |